Return to Faculty Profiles

Faculty


Joseph Nathan

Joseph P. Nathan

Associate Professor, Pharmacy PracticeDirector, International Drug Information Center

B.S. Pharmacy: Arnold & Marie Schwartz College of Pharmacy and Health Sciences, LIUM.S. Drug Information and Communication: Arnold & Marie Schwartz College of Pharmacy and Health Sciences, LIUPharm.D. University of Arkansas for Medical Sciences

Description

Dr. Joseph Nathan is an alumnus of the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, having earned a B.S. in pharmacy and an M.S. in drug information from the College. He earned his Doctor of Pharmacy degree from the University of Arkansas for Medical Sciences. After practicing as a clinical pharmacist at Maimonides Medical Center in Brooklyn, Dr. Nathan joined the College’s International Drug Information Center as a drug information specialist. Currently, he is an associate professor in the Division of Pharmacy Practice and the director of the College’s International Drug Information Center. His scholarly interests focus on the availability and utilization of information resources by healthcare professionals and consumers. Dr. Nathan published numerous articles on issues affecting the practice of pharmacy, serves as a reviewer for professional publications, and has served on the advisory board of a leading pharmacy journal. Dr. Nathan served as a pharmacy consultant to a long-term-care facility and continues to practice in a community pharmacy.

Specialties

Drug information services, drug information resources, professionals’ and consumers’ health literacy

Publications

Nathan JP, Drug Information Rounds. Pharmacy Education, 2015;15(1)252 – 253.

Nathan JP, Vider E. The package insert. US Pharmacist. 2015;40(5):8-10.

Nathan JP. “Drug information – the systematic approach. J Pharm Pract. 2013;26:78-84.

Nathan JP, Grossman S. Professional Reading Habits of Pharmacists Attending 2 Educational Seminars in New York City. J Pharm Pract. 2012;25(6):600-5.

Nathan JP, Gim S. Responding to drug information requests. Am J Health Syst Pharm. 2009; 66: 706-711.

Rosenberg JM, Schilit S, Nathan JP, Zerilli T, Mcguire H. An update on the status of 89 drug information centers in the United States. Am J Health Syst Pharm. 2009;66:1718-22.

Nathan JP, Zerilli T, Cicero LA, Rosenberg JM. Patients’ use and perception of medication information leaflets. Ann Pharmacother. 2007;41:777-782.

Rosenberg JM, Zerilli T, Nathan JP, Mcguire H. Use of statins and gemfibrozil in patients with type 2 diabetes mellitus and cardiovascular risk factors attending adult day health care centers: an opportunity for pharmacists. Consult Pharm. 2007; 22:38-44.

Nathan JP, Cicero LA, Koumis T, Rosenberg JM, Feifer S, Maltz F. Availability of and attitudes towards resources on alternative medicine products in the community pharmacy setting. J Am Pharm Assoc. 2005;45:734-9.

Rosenberg JM, Koumis T, Nathan JP, Cicero LA, Mcguire H. Current status of pharmacist-operated drug information centers in the United States. Am J Health-Syst Pharm. 2004; 61:2023-32.

Koumis T, Cicero LA, Nathan JP, Rosenberg JM. Directory of pharmacist-operated drug information centers in the United States - 2003. Am J Health-Syst Pharm. 2004; 61:2033-42.

Koumis T, Nathan JP, Rosenberg JM, Cicero LA. Strategies for the prevention and treatment of statin-induced myopathy: Is there a role for ubiquinone supplementation? Am J Health-Syst Pharm. 2004;61:515-519.

Nathan JP, Castellanos J, Rosenberg JM, Cicero LA. Impact of aspirin on the gastrointestinal-sparing effects of cyclooxygenase-2 inhibitors. Am J Health-Syst Pharm. 2003;60:392-394.

Rosenberg JM, Nathan JP, Plakogiannis F. Weight variability of pharmacist-dispensed split tablets. J Am Pharm Assoc. 2002;42:200-205.

Nathan JP, Rosenberg JM. A survey of fee-for-service activities of drug information centers in the US. Hospital Pharmacy 2000;35:837-840,896.

Other Publications

Nathan JP. Introduction: drug information. J Pharm Pract. 2013;26:76-77.

Zerilli T, He A, Nathan JP, Grossman S. To Substitute or Not to Substitute: That is the Question. Pharmacy Times. 2011;77(3):68,70,71.

Rosenberg JM, Schilit S, Nathan JP. Which oral solid medications should be protected from light/or moisture? Drug Topics. 2008;152(26):29.

Rosenberg JM, Domovich A, Nathan JP, Schilit S. Viewpoint: Should an RX label require a use-by date or an expiration date? Drug Topics. 2008;152(3):68.

Nathan JP, Schilit S, Rosenberg JM. Can lactose-intolerant patients use lactose-containing medications? Drug Topics. 2008; 152(2):11.

Ayrapetova N, Nathan JP. What are the right OTCs to treat cough associated with the common cold? Drug Topics 2007;151(3):58-59.

Agojo MC, Zerilli T, Nathan JP, Cicero LA. What’s the latest in vaccine therapy? Drug Topics 2006; 150(23):39-40.

Nathan JP, Koumis T, Rosenberg JMR. Sublingual nitroglycerin – are we counseling patients properly? Drug Topics 2005; 149(17):16.

Koumis T, Nathan JP, Rosenberg JM. What is bioidentical HRT and is there evidence to support its use? Drug Topics 2005;149(9):29.

Koumis T, Cicero LA, Nathan JP, Rosenberg JM. What are the current and emerging strategies to improve low HDL-C levels? Drug Topics. 2004;148(21):20-1.

Shah M, Nathan JP, Koumis T, Rosenberg JM. Was the FDA justified in banning ephedra-containing products? Drug Topics. 2004;148(5):68,71.

Nathan JP, Rosenberg JM. Who should get the flu vaccine and who shouldn't? Drug Topics. 2003;147(Nov. 17):28,30.

Nathan JP, Cicero LA, Rosenberg JM. Should patients on doxycycline avoid dairy products? Drug Topics. 2003;147(Oct. 20):21.

Koumis T, Nathan JP, Rosenberg JM. What is the role of C- reactive protein in cardiovascular disease assessment and how do you treat elevated levels? Drug Topics. 2003. 147(15):30.

Koumis T, Nathan JP, Rosenberg JM. Can grapefruit juice be safely taken with drugs? Drug Topics. 2002;146(20):19.

Nathan JP, Joa G, Roizen M, Rosenberg JM. Are sulfonamides, sulfones, sulfites, and sulfates contraindicated in patients with a reported “sulfa” allergy? Drug Topics. 2002. 146(15):37.

Grossman SS, Nathan JP, Rosenberg JM. Should bitter melon be used for the treatment of diabetes mellitus? Drug Topics. 2001;145(18):23.

Plakogiannis R, Nathan JP, Rosenberg JM. How are insulin glargine and insulin aspart different from the older insulins? Drug Topics 2000; 144(22):41.

Nathan JP, Castellanos JT, Rosenberg JM. Should folic acid be added to reduce risk for cardiovascular disease? Drug Topics 2000;144(18):34.

Nathan JP, Cicero LA, Rosenberg JM. Can insulin be administered via nonparenteral routes? Drug Topics 2000;144(5):40.

Castellanos JT, Nathan JP, Rosenberg JM. Is dipyridamole making a comeback? Drug Topics 1999;143(21);58.

Rosenberg JM, Nathan JP, Cicero LA. Pharmacist-operated drug information centers in the United States: A directory of centers that meet listed cirteria-1999. Hospital Pharmacy 1999;34:797-798,801-804,807-808,810.

Nathan JP, Khodzhayev A, Rosenberg JM. Can cholesterol-lowering margarines replace drug therapy? Drug Topics 1999;143(15):31.

Martinez R, Nathan JP, Cicero L, Rosenberg JM. Are there any risks associated with calcium intake? Drug Topics 1999;143(12):34.

Nathan JP, Cicero LA, Fung H, Rosenberg JM. What medications should be avoided in the elderly? Drug Topics 1999;143(8):30.

Nathan JP, Cicero L, Rosenberg JM. What are the differences between the new fluoroquinolones? Drug Topics 1999;143(3):35.

Nathan JP, Hembree JW, Cicero LA, Rosenberg JM. What is the therapeutic potential of COX-2 inhibitors? Drug Topics 1998;142(20):28.

Nathan JP, Srulovich S, Cicero L, Rosenberg JM. Should creatine be recommended to athletes? Drug Topics 1998;142(16):58.

Cicero LA, Nathan JP, Rosenberg JM. What is the role of antileukotrienes in the management of asthma? Drug Topics 1998;142(10):28,31.

Lectures and Presentations

Abstracts/Poster Presentations

Nathan, JP, Grossman s, Zerilli T, “Partnering with a community-based social service agency to promote optimal medication use”, AACP Annual Meeting. Grapevine, TX, 2014.

Gropack S, Kirschenbaum HL, Nathan JP, Flower S. Development of an Interprofessional Education (IPE) Program for Health Care Students Across 12 Disciplines. Combined Sections Meeting of the American Physical Therapy Association, February 4-6, 2014, Las Vegas, Nevada.

Nathan JP, Grossman S, “Professional reading habits of pharmacists.”, APhA 2012 Annual Meeting & Exposition, New Orleans, Louisiana., 2012

O’Brien PG, Nathan JP, Shah B, Keogh T., “Patient Knowledge of Psychiatric Medications at Time of Discharge from Psychiatric In patient Unit”, Annual New York-Presbyterian Hospital and The Methodist Hospital Collaborative Nursing Research and Evidence-Based Practice Symposium, Houston, Texas., 2011

Nathan JP, Schilit S, Zerilli T, Tykhonova I, Mayzel P. Functions served by salaried pharmacy intern in hospitals. Abstract presented at the ASHP Midyear Clinical Meeting, December 7-8, 2009, Las Vegas, Nevada.

Nathan JP, Zerilli T, Cicero L, Rosenberg JM. Patients’ use and perception of medication information leaflets. Abstract presented at the APhA 2007 Annual Meeting & Exposition, March 16-19, 2007, Atlanta, Georgia.

Books/Book Chapters

Nathan JP, Rosenberg JM, Davis J. Pharmacy services. In: Long-Term Care Survey and Certification Guide. Markenson AJ, Hurley B. eds. Chapel Hill, NC: Eli Research, Inc; 2000:1501-1541.

Grants/Contracts

Richardson, C. Ho, J. Nathan, L. Borno, T. Sweeney, S. Flower. Optimizing Patient Care through Interprofessional Education. Grant awarded by New York State Council of Health Systems Pharmacists Research and Education Foundation. $2000. March 2012.

Honors/Awards

2013 Founder’s Award for Faculty, awarded by the College of Pharmacy, Long Island University, May 2013

Outstanding Advisor Award, Arnold & Marie Schwartz College of Pharmacy and Health Sciences. August 2007.

Member of the Beta Kappa chapter of Phi Lambda Sigma, Pharmacy Leadership Society.

Member of the Beta Theta chapter of Rho Chi, Pharmacy Academic Honor Society.

Professional Affiliations

Member, American Society of Health-System Pharmacy

Other Professional Activities

Member, Professional Advisory Committee, Cobble Hill Health Center, Long Term Health Care Program; 2006-2010.

International Advisory Board, Current Medical Research and Opinions (CMRO); 2008-December 2009.

Advisory Board Member, American Journal of Health-System Pharmacy; January 2006-January 2009.

Reviewer, Current Medical Research and Opinion

Reviewer, American Journal of Health-System Pharmacy

Reviewer, Journal of the American Pharmacists Association

Reviewer, USP disease monographs (2000).

Associate Editor, PDR for Herbal Medicines, first edition, Medical Economics Company.

Associate Editor, PDR for Herbal Medicines, second edition, Medical Economics Company.

Contributing Editor, ePocrates Drug Information Database.

Examiner, New York State pharmacy licensing examination (part III).

Consultant, Provision of expert opinion concerning a number of legal cases.